Literature DB >> 18468936

Interleukin-1 receptor antagonist gene polymorphisms are associated with disease severity in Black South Africans with rheumatoid arthritis.

Steven Lubbe1, Mohammed Tikly, Lize van der Merwe, Bridget Hodkinson, Michele Ramsay.   

Abstract

OBJECTIVE: To test for genetic associations between polymorphisms of the interleukin-1 (IL-1) gene cluster and disease susceptibility and severity in Black South Africans with rheumatoid arthritis (RA).
METHODS: Allele and genotype frequencies of IL1B (-511) and (+3954) and IL1RN variable number of tandem repeat (VNTR) and (+2018) were compared between 141 RA patients and 101 healthy controls.
RESULTS: No significant differences in allelic distribution at the four loci were observed between RA patients and controls. Within the RA group, the IL1RN*2 (two repeats of an 86bp tandem repeat) at the IL1RN VNTR locus was independently associated with higher Larsen radiologic damage scores (LDS), corrected for disease duration (p=0.04). Moreover, the inferred haplotype, consisting of IL1RN*2 and (+2018) 'C' allele, was associated with significantly higher LDS, on average 15 points higher, compared to the base haplotype of IL1RN*long (three or more repeats) and (+2018) 'T' allele (p=0.009). The common IL1B (-511) 'T' allele was associated with a poorer modified health assessment questionnaire disability index (p=0.02).
CONCLUSION: Our findings provide further evidence of a possible role of polymorphisms of the IL-1 gene cluster in disease severity in RA, and particularly IL1RN*2 as a marker of erosive joint damage in Black South Africans with RA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18468936     DOI: 10.1016/j.jbspin.2007.09.015

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  5 in total

1.  Association of 86 bp variable number of tandem repeat (VNTR) polymorphism of interleukin-1 receptor antagonist (IL1RN) with susceptibility and clinical activity in rheumatoid arthritis.

Authors:  S Ramírez-Pérez; M Salazar-Páramo; S Pineda-Monjarás; U De la Cruz-Mosso; J Hernández-Bello; G E Martínez-Bonilla; A L Pereira-Suárez; J F Muñoz-Valle
Journal:  Clin Rheumatol       Date:  2017-03-25       Impact factor: 2.980

2.  Pro-inflammatory cytokine response pre-dominates immuno-genetic pathway in development of rheumatoid arthritis.

Authors:  E K Krishna Priya; Lekshmy Srinivas; S Rajesh; Kesavarao Sasikala; Moinak Banerjee
Journal:  Mol Biol Rep       Date:  2020-10-19       Impact factor: 2.316

3.  Distribution of the IL-1RN, IL-6, IL-10, INF-γ, and TNF-α Gene Polymorphisms in the Mexican Population.

Authors:  Gilberto Vargas-Alarcon; Julián Ramírez-Bello; Teresa Juárez-Cedillo; Silvestre Ramírez-Fuentes; Silvia Carrillo-Sánchez; José Manuel Fragoso
Journal:  Genet Test Mol Biomarkers       Date:  2012-09-12

Review 4.  Interleukins and interleukin receptors in rheumatoid arthritis: Research, diagnostics and clinical implications.

Authors:  Lili Magyari; Dalma Varszegi; Erzsebet Kovesdi; Patricia Sarlos; Bernadett Farago; Andras Javorhazy; Katalin Sumegi; Zsolt Banfai; Bela Melegh
Journal:  World J Orthop       Date:  2014-09-18

5.  The Clinical Significance of Interleukin-1 Receptor Antagonist +2018 Polymorphism in Rheumatoid Arthritis.

Authors:  Endom Ismail; Omimah Khaled Jaber Nofal; Rajalingham Sakthiswary; Syahrul Sazliyana Shaharir; Radhika Sridharan
Journal:  PLoS One       Date:  2016-04-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.